The store will not work correctly when cookies are disabled.
N-(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)benzamide
ID: ALA4797183
PubChem CID: 162675742
Max Phase: Preclinical
Molecular Formula: C14H11N5O
Molecular Weight: 265.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1nc(-c2cccnc2)n[nH]1)c1ccccc1
Standard InChI: InChI=1S/C14H11N5O/c20-13(10-5-2-1-3-6-10)17-14-16-12(18-19-14)11-7-4-8-15-9-11/h1-9H,(H2,16,17,18,19,20)
Standard InChI Key: JPJWLXDMTIOTSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
16.6137 -9.0297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2660 -8.5320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9946 -7.7569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1711 -7.7784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9381 -8.5661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0535 -8.7647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1639 -8.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5457 -8.3082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7721 -8.5811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6192 -9.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2501 -9.9206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0212 -9.6449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6508 -8.1985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4383 -8.4353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4565 -7.3996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6262 -9.2324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4128 -9.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0111 -8.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8133 -8.0963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0269 -7.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
2 6 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
6 13 1 0
13 14 1 0
13 15 2 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.28 | Molecular Weight (Monoisotopic): 265.0964 | AlogP: 2.12 | #Rotatable Bonds: 3 |
Polar Surface Area: 83.56 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.39 | CX Basic pKa: 3.73 | CX LogP: 2.51 | CX LogD: 2.47 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.76 | Np Likeness Score: -2.03 |
References
1. Korff M,Imberg L,Will JM,Bückreiß N,Kalinina SA,Wenzel BM,Kastner GA,Daniliuc CG,Barth M,Ovsepyan RA,Butov KR,Humpf HU,Lehr M,Panteleev MA,Poso A,Karst U,Steinmetzer T,Bendas G,Kalinin DV. (2020) Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action., 63 (21): [PMID:33089691] [10.1021/acs.jmedchem.0c01635] |